Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA Gains 6%; BSE HEALTHCARE Index Down 0.8%
Thu, 3 Oct 12:37

ALEMBIC PHARMA Gains 6%; BSE HEALTHCARE Index Down 0.8%Image source: peterschreiber.media/www.istockphoto.com

ALEMBIC PHARMA share price has zoomed 6% and is presently trading at Rs 1,250.0.

Meanwhile, the BSE HEALTHCARE index is at 43,909.9 (down 0.8%).

Among the top gainers in the BSE HEALTHCARE index today are GRANULES INDIA (up 3.0%) and ERIS LIFESCIENCES (up 2.1%).

J.B.Chemicals (down 3.8%) and APOLLO HOSPITALS (down 3.7%) are among the top losers today.

Over the last one year, ALEMBIC PHARMA has moved up from Rs 790.9 to Rs 1,250.0, registering a gain of Rs 459.2 (up 58.1%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,428.9 to 43,909.9, registering a gain of 54.5% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 161.5%), SUVEN PHARMACEUTICALS (up 108.4%) and Glenmark Pharma (up 97.2%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 82,890.6 (down 1.6%).

The top losers among the BSE Sensex today are Asian Paints (down 3.8%) and Tata Motors (down 3.7%). The most traded stocks in the BSE Sensex are HDFC Bank and Reliance Ind..

In the meantime, NSE Nifty is at 25,387.4 (down 1.6%). BPCL and IOC are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,512.1 to 82,890.6, registering a gain of 17,378.5 points (up 26.5%).

ALEMBIC PHARMA Financial Update...

ALEMBIC PHARMA net profit grew 11.3% YoY to Rs 1,342 million for the quarter ended June 2024, compared to a profit of Rs 1,206 million a year ago. Net sales rose 5.1% to Rs 15,617 million during the period as against Rs 14,862 million in April-June 2023.

For the year ended March 2024, ALEMBIC PHARMA reported 80.1% increase in net profit to Rs 6,158 million compared to net profit of Rs 3,420 million during FY23. Revenue of the company grew 10.2% to Rs 62,286 million during FY24.

The current Price to earnings ratio of ALEMBIC PHARMA, based on rolling 12 month earnings, stands at 39.0.


Equitymaster requests your view! Post a comment on "ALEMBIC PHARMA Gains 6%; BSE HEALTHCARE Index Down 0.8%". Click here!